Diagnose and triage faster during this years
Tridemic of respiratory infections.

This winter a tridemic of respiratory infections from influenza, Covid-19 and RSV is expected to raise the risk of serious illness for vulnerable groups and increase the burden on emergency rooms and primary healthcare.

Whilst pre-pandemic, global seasonal incidences were estimated to be

As we head into the colder weather of winter, transmission of all three infections will start to increase so it is as important as ever for healthcare providers to be prepared with the tools they need to manage incoming patients, prevent onward transmission and provide the right treatment when needed.

How can the LumiraDx Platform help?

Implement infection control measures quickly during this winter’s tridemic, with lab-accurate results in minutes across all 3 tests, from a single swab sample.*


The LumiraDx Platform offers reliable, portable testing to quickly identify patients with SARS-CoV-2, Flu A/B or RSV, using a combination of high-sensitivity respiratory tests.


By using both LumiraDx SARS-CoV-2 & Flu A/B and SARS-CoV-2 & RSV tests you can test for all three from a single swab sample* in 12 minutes if tests are run concurrently, or 24 minutes if run one after the other.



The latest SARS-CoV-2 variants, Eris variant EG.5.1 and Pirola variant BA.2.86 can be detected by any of the LumiraDx SARS-CoV-2 Ag tests.

1) https://covid19.who.int/. Accessed 19th September 2023
2) PAHO/WHO | WHO launches new global influenza strategy. Accessed 19th September 2023
3) Shi, T. et al. (2017) Global, regional, and national disease burden estimates of acute lower infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Vol 390, Issue 10098, p946-958.

*Swab used must be validated for use with both tests - refer to swab technical bulletins